NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$186.76M
Total Shares
1.58M
Net Share Change
+300.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$186.76M1.58M shares
ADD+300.0K(+23.4%)